InsidersTradesSigma
Track the Annexin Pharmaceuticals AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Annexin Pharmaceuticals AB (publ) has recorded 3 reports. Market capitalisation: €86.7m. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: Mikael Lönn. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Annexin Pharmaceuticals AB (publ) is a Swedish pharmaceutical company focused on developing treatments for inflammatory diseases and cardiovascular disorders. It is listed on the Stockholm Stock Exchange (XSTO).